B. Braun Melsungen AG

B. Braun Melsungen AG is a medical technology company headquartered in Melsungen, Germany. It develops and delivers medical technologies and integrated healthcare solutions to protect and improve people's health worldwide. Founded in 1839, when Julius Wilhelm Braun purchased the Rose Pharmacy in Melsungen for 14,000 thalers, the company employs more than 64,000 people and records annual sales of approximately €9.4 billion. It has remained under the stewardship of the Braun family for six generations and operates on every continent.

The company's work spans medical technology and pharmaceutical production, with technical domains including infusion therapy technology, clinical nutrition, extracorporeal blood treatment and dialysis, surgical instruments and technology, herbal and natural remedies, and mail-order pharmacy services. Products include Braunüle, a single-use plastic infusion device introduced in the 1950s; Lipofundin, a clinical nutrition product pioneered in 1962; dialysis machines for extracorporeal blood treatment; and surgical instruments and innovations delivered through the Aesculap division.

Product development has historically been driven by patient safety and comfort, a line running from early natural herbal remedies to advanced medical technology. The company describes a culture of continuous innovation and an emphasis on integrated healthcare solutions, alongside an entrepreneurial heritage tracing back to its founder's modest initial capital.